APT Medical Inc.
688617
株式のランク
#3231
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
株価
$38.62
時価総額
$5.47B
変化（1日）
0.19%
変化（1年）
-17.07%
国
CN
取引 APT Medical Inc. (688617)
カテゴリー
Healthcare
APT Medical Inc.（688617）の利益
Jun 2026 時点の利益 TTM: $158.75M
APT Medical Inc. の最新の財務報告によると、同社の現在の利益は $158.75M です。2024 年には $102.20M の利益を上げ、これは 2023 年の利益 $84.25M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
APT Medical Inc. の利益の推移（2017 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $158.75M | 18.63% |
| 2025 | $133.82M | 30.94% |
| 2024 | $102.20M | 21.31% |
| 2023 | $84.25M | 47.08% |
| 2022 | $57.28M | 64.33% |
| 2021 | $34.86M | 87.86% |
| 2020 | $18.55M | 41.43% |
| 2019 | $13.12M | 288.78% |
| 2018 | $3.37M | -29.16% |
| 2017 | $4.76M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $6.56B | 4,033.47% |
US
|
|
| $6.60B | 4,059.29% |
IE
|
|
| $5.15B | 3,142.78% |
US
|
|
| $3.86B | 2,332.08% |
US
|
|
| $3.25B | 1,947.21% |
DE
|
